Health Secretary Robert F. Kennedy Jr. announced a slate of eight new members to serve on the Advisory Committee on ...

The U.S. Food and Drug Administration has approved Moderna’s (NASDAQ:MRNA) RSV vaccine, mRESVIA (mRNA-1345), for preventing ...

Some public health experts have expressed optimism that RFK Jr.'s picks to lead the Advisory Committee on Immunization ...

Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS ...

Researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering have developed a compound that could work as a ...

About 30% of all respiratory tract infections are caused by coronaviruses, leading to widespread illnesses and, in some cases, to epidemic and even pandemic outbreaks, as we experienced with the COVID ...

HHS Secretary Robert F. Kennedy Jr. said he's disbanding the CDC's Advisory Committee on Immunization Practices (ACIP) in order to "restore trust" in U.S. vaccine science. In an HHS press release, the ...

U.S. Health Secretary Robert F. Kennedy Jr. on Wednesday named eight new vaccine policy advisers to replace the panel that he ...

Some appointees hold some of Kennedy’s more critical views on vaccines, while other picks appear to be olive branches to ...

The FDA expanded the approval of Moderna’s RSV vaccine, extending the license to include more adults and giving the company a welcome win.

Moderna said the Food and Drug Administration expanded its approval of the pharmaceutical company's respiratory syncytial virus vaccine, mResvia, to adults aged 18-59 at increased risk for the disease ...

Paul Brett’s lab leads pioneering work in melioidosis research, diagnostics and vaccine development through cross-continental collaboration ...